Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported a transaction involving Guardant Health, Inc. stock on September 30, 2024.
Summary
- On September 30, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving the company's common stock.
- Krognes acquired 154 shares of common stock at a price of $0.
- This acquisition was related to the vesting of restricted stock units.
- Following the transaction, Krognes directly owns 9,757 shares of Guardant Health, Inc.
- Krognes also directly owns 3,240 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by a company director, with no inherent positive or negative implications.
Industry Context
This is a standard SEC Form 4 filing, which is a routine part of corporate governance and transparency, providing insight into the transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| August 9, 2022 | Date of restricted stock unit award grant. |
| June 30, 2023 | 25% of restricted stock units vested. |
| September 30, 2024 | Date of transaction: acquisition of 154 shares of common stock due to vesting of restricted stock units. |
| October 01, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.